CIS has been reported in 85% of people who developed MS 4 . On the other hand, only 63% of those who present with CIS will develop MS over 20 years 7 . Optic Neuritis (ON) is one of the most common forms of CIS as well as presenting symptoms of MS 8 . Consequently, its conversion to MS has been of particular interest to many researchers, who have reported a diverse range of as low as 12% amongst Mexican patients 9 to a higher rate of 75% in Great Britain 10 . The scope of the figures could be explained by a number of factors, including different population with diverse genetic and environmental backgrounds as well as study design, patient selection, length of follow up, change in methods of clinical evaluation and effect of therapy 11 . Different studies reported several risk factors with various weights on the process of emerging as a full blown MS. Among them, genetic background 2, 12 , gender 13, 14 , smoking 15, 16 , latitude 17 , vitamin D level 18, 19 , month of birth 20 , and CIS 7 are the most emphasized factors. Since ON is one of the most common manifestations of MS, understanding of the important risk or protective factors can alert physicians of patients who are prone to developing MS over the years. This information could be helpful for making decisions concerning pharmacologic intervention. Several clinical and paraclinical features, such as gender, age, abnormal magnetic resonance imaging (MRI), evoked potentials changes, oligoclonal band changing, and season of ON attack were found as probable predictors of development of MS after an ON attack 2, 8, 11, [21] [22] [23] [24] . Optic Neuritis Treatment Trial (ONTT) reported that simultaneous MRI abnormalities at ON attack has strong predictor effect of MS developing; in contrast, optic disc swelling and male sex are against developing MS in future 22 . Although ONTT informed several well established reports, every region should consider their own statistics based on their specific genetics, lifestyle background and environmental exposures. Previously, the prevalence and incidence of MS in Iran was reported as 44 and 3.6 per 100,000 people, which is higher than Asian and African countries but comparable to the Western world 3 . In the present study, we attempted to consider all probable risk factors involved in developing MS and the effects of pharmacologic intervention in a single referral university hospital.
MATERIAL & METHODS
Retrospectively, from March 2001 to January 2009, records of Iranian patients with a first attack of acute ON, referred to the neurology and ophthalmology clinics of Rasool Akram University Hospital, were reviewed. Demographic and clinical information was extracted based on a predefined data sheet. The gathered data included age, sex, telephone number, first admission date, age at the time of ON diagnosis and MS, past medical history, drug history, both eyes evaluation on admission and discharge, recurrence of ON, baseline and follow up MRI, Visual Evoked Potential (VEP), cerebrospinal fluid (CSF) analysis, relative afferent pupillary defect (RAPD), serologic studies for vasculitis disorders, type and dosage of therapies. The Institutional Review Board approved our study be done and all patients reached through phone provided their oral informed consent before proceeding with the questionnaire.
Follow up of patients
All patients were later contacted by telephone and appointments were arranged to perform physical exams and review their medical records. Where the patient was not accessible, two attempts were made on the same day to contact them, a further two attempts the following days and (to the extent that we were unable to reach him/her), an additional two week trial with the same structure was carried out. If the person was still not accessible, he/she was then considered beyond our reach, although all the information in the chart review was maintained. All the phone calls were made on working days in the afternoon. During the phone call patients were asked about ON recurrence, other symptoms of MS, whether they were diagnosed clinically as having MS and any treatment. The flow chart of patient recruitment is summarized in Figure 1 .
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Elaboration of variables
The process of ophthalmic evaluation involved the checking of optic disc edema and looking for papilitis or retrobulbar involvement; visual acuity was determined by Snellen chart and then converted to log MAR to make it more suitable for analysis. A new variable named "affected eye" visual acuity was made based on Log MAR numbers. Those who had both eyes involvement the worse (higher) value was considered for further analysis. To make categorical variables, the log MAR was transformed to mild, moderate and severe categories based on log MAR VA ≤0.3, between 0.3 and 1.0 and ≥1, respectively. Treatment information such as dosage and route of administration (intravenous or oral) was registered and if the patients received taper therapy after initial dose, this was also recorded. Brain and cervical MRI were used 25 to look for parenchymal lesions and eventually were categorized as normal, abnormal with space positive lesions and MS like lesions which did not meet space positive criteria 26 . Presence of oligoclonal band and/or IgG index of higher than 0.6 were considered as abnormal CSF analysis.
ON and MS definition
Recurrent ON was not considered as a factor of CDMS diagnosis. Optic Neuritis that lasted more than 24 hours with seven days progression, accompanied by pain on eye movements, decreased visual acuity, dyschromatopsia and visual field defect, which were not associated with fever and/or other neurological disorders were considered as acute attacks of ON. The diagnosis of clinically definite MS was based on the McDonald and revised McDonald Criteria diagnostic scheme 26, 27 .
Statistical analysis
Numerical data was expressed as mean ± standard deviation (SD Table 1 : Demographic characteristics and MRI and therapeutic findings of all patients with first attack of ON as well as those who were followed over years tests were used for numerical data which did not follow normal distribution. Categorical variables were compared using the chisquare test. Survival analysis and cox regression analysis were done to assess rate of developing CDMS and contributing predicting factors. Date of diagnosis of ON was considered as "starting point". Whether the patient were diagnosed as CDMS or not was considered the endpoint of the present study and the attributed date to CDMS diagnosis and last follow up (either the most recent in person evaluation or telephone assessment) for those who did not develop MS was considered the last date of being under the study. Survival curves were made using the Kaplan-Meier method and Life table methods were used to assess the cumulative probability of MS development. Those variables which had a P value less than 0.2 in univariate analysis and/or had biologic plausibility and without more than 20% missing data were used to develop cox proportional hazards model with a conditional backward method. Hazards ratios are reported with 95% confidence interval (CI). Reported P values are all two-tailed and those less than 0.05 were considered statistically significant. Statistical analysis was performed using the SPSS 16.0 software package (IBM Corp., Somers, NY, USA).
RESULTS
Characteristics of all enrolled patients
General measures
Over eight years, 219 patients [mean age (SD): 27.4 (9.1), range: 9-57, female: 83%] with the first attack of acute ON and without any history of being marked as probable or definite MS were selected for this study, (Table 1) . A large proportion of our patients (63.9%) were aged between 20 and 40 years. All patients underwent corticosteroid therapy with different dosage and route of administration [3 g intravenous (IV) in 65; 5g IV in 125; 3g IV followed by oral tapering in 10; 5g IV followed by oral tapering in 19 cases]. The seasonal distribution of ON attacks is shown in Table 1 .
Ophthalmic findings
Two hundred and seven patients (94.5%) had unilateral [right: 99 (47.8%); left: 108 (52.2%)] and 12 (5.5%) suffered from bilateral ON attack. One hundred and fifty-two patients (69.4%) had retro-bulbar ON with sharp and pink optic disc. The distribution of either right/left or papillitis/retrobulbar eye involvement was not different among age categories of younger than 20, between 20 and 40 and more than 40 years-of-age. 37.8% of males and 29.1% of females had papillitis (p=0.2). Among 219 cases, 70 patients had normal visual acuity at discharge time, (Figure 2 ). Mean visual acuity (SD) of affected eye on admission and discharge were 1.7 (0.9) and 0.7 (0.9), respectively (p<0. Table 3 : The unadjusted and adjusted relative hazard of developing CDMS in patients presenting with first attack of acute optic neuritis using cox regression model (Table 2) . VEP was done in 20 followed cases and was abnormal in ten (62.5) and six (37.5) of those with and without diagnosis of MS, respectively (p=0.2). Tables 1 and 2 . There was a lower rate of CDMS development among patients who were older than 40 years old in comparison to the younger patients. Among the 109 patients with follow up, 40 patients had normal visual acuity at discharge, of which 11 cases developed MS later on.
Paraclinical Findings
Characteristics of all followed patients
The mean ages (SD) of men and women were 25.5 (8.4) and 26.4 (8.4), respectively (p=0.6). Among the male gender, the mean age (SD) of patients developing MS was significantly less than those who did not develop MS [18.3 (2.8) Thirty-one cases had at least another episode of ON with mean interval time (SD) of 12.1 (1.3) months. Three of these patients had bilateral eye involvement on first admission. Among those with the second unilateral eye involvement, the lateralization was statistically different between the two attacks, i.e. those who had right eye involvement at admission (11) , developed left eye ON at the recurrence (8, 72.7%) or those who had left eye involvement at admission (17) , developed right eye (12, 70.6%) involvement at the second attack (P=0.05). Among those who had more than one ON attack (n=31), 19 were followed up and 5 of them (26.3%) developed CDMS. A further two patients suffered three attacks of ON and both went on to developed MS.
After one year of follow-up, 16% of the cases progressed to CDMS. The values after two and five years were 27% and 45%, respectively (Figure 3) . The longtime effect of gender, MRI findings, and corticosteroid therapy on developing CDMS is depicted in Figure 3 . Gender, number of ON attacks, lateralization of eye involvement, corticosteroid therapy, abnormal MRI findings, VA of affected eye on admission and THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
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Figure 3: Kaplan-Meier curves showing effect of time (A), gender (B), MRI findings (C) and initial corticosteroid therapy (D) in developing CDMS over time.
discharge were used for univariate and multivariate analysis ( (Table 3) .
DISCUSSION
A clinically isolated syndrome (CIS) is an attack compatible with MS, and ON is one of the most common forms of CIS. An episode of CIS can create a diagnostic and therapeutic dilemma. 63% of those who present with CIS will progress to MS over a period of 20 years 7 . Some evidences suggest that early treatments may improve the eventual outcome 28 . Our study showed that the risk of developing CDMS two and five years after an initial ON attack in Iranian patients would be 27% and 45%, respectively. Stratifying based on gender, showed that younger men stand a higher risk of developing CDMS. Gender, MRI lesions, oligoclonal band in CSF, bilateral eye involvement and high dose corticosteroid therapy play a role in defining the risk of developing CDMS. However, only MRI lesions, bilateral eye involvement and high dose corticosteroid therapy were independently associated with an increased risk of developing CDMS. Although corticosteroid therapy was very helpful in prompt visual recovery, the high dosage may nonetheless eventually contribute to unwanted clinical development of CDMS.
The rate of CDMS development after an attack of ON was relatively high in our study in comparison to other Asian countries 21, 23 and is comparable to Western ones 11, 22, 29 , see Table  4 . This disparity could be explained by genetic backgrounds such as common origin of European countries and Iranians from Arian descent while other mentioned Asian countries consist of different ethnicities. Our values are higher than those previously reported from Iran 30 which mostly could be explained by the use of different MS definitions (Poser vs. McDonald), sample size (56 vs. 109), method of analysis and length of follow up. However, it could be due to a change in conversion rate of ON into CDMS which can be explained by the high prevalence and incidence of MS in Iran 3 . Our results showed that the female sex carries a higher risk of developing CDMS in the future but in multivariate cox regression analysis its effect is to some extent masked by the presence of lesions in MRI findings which is consistent with ONTT 22 . Once we tried to check for factors involved in developing CDMS by gender, sign of ON attack at a young age was an important predictor of CDMS development in the male sex. Spring and Winter were the most frequent seasons during which ON attacks occurred. In conducting our research for MRI lesions, we found that Spring was the most common season for ON in patients with abnormal MRI findings. The ON was mostly retrobulbar which is consistent with Western countries 8, 22 but not Eastern ones 21, 23 . Although the CDMS development was higher among retrobulbar cases (35% vs. 31% non-retrobulbar cases), it was not statistically significant. Our results showed that bilateral ON is an important risk factor in the development of CDMS and can increase the probability of developing CDMS six-fold. This is consistent with the Hutchinson report which studied 136 cases with ON and found that the rate of developing MS was higher in patients with bilateral ON than those with unilateral ON (65% vs. 44% respectively) 31 . Other studies have not selected bilateral ON in their studies which makes comparison impossible. The VA on admission was not associated with CDMS development. However, VA at discharge could be a potential risk factors for developing CDMS in the future but it needs to be confirmed with more patients.
We could not find any association between abnormal VEP and development of CDMS; however, those who had oligoclonal band in CSF developed CDMS over time which is consistent with previous studies 8, 21, 32 . There is a strong link between normal MRI and lower rate of the development of CDMS ( Figure 3 and Table 3 ) which confirms the ONTT results as well as others 8, 22, 23 . On the other hand, abnormal findings on MRI should be approached seriously with proper treatment as well as short interval follow ups.
Corticosteroids have been used as one of the most common forms of therapy in acute ON. It also had promising results in relieving the visual difficulties of our patients. Our results illustrated that both 3 and 5 gram therapies improved visual acuity of the patients during their acute phase of attack. This is consistent with the results of the ONTT and Sellebjerg et al studies. 28 Moreover, we found that the 3 gram therapy method appeared to generate better initial outcome. The ONTT study illustrated that 3 grams IV corticosteroid therapy followed by a two weeks taper will accelerate visual recovery, however, Vedula et al were not able to describe effectiveness of corticosteroid therapy 33 . In their systematic review they were not able to conclude on the effectiveness of corticosteroid therapy on visual acuity improvement. It seems that their report should be interpreted cautiously as they were not able to conduct further analysis due to heterogeneity of data.
According to our data, those who managed with a higher dose (5g) of corticosteroid therapy, had more chance of developing CDMS than those treated with a lower dose (3g), [ Figure 3 ]. Some may claim that those who got higher dose had worse VA on admission but the distribution of corticosteroid dosage and severity of VA impairment was not statistically significant which would reject this hypothesis. Furthermore, the treatment strategy was not based on severity of visual acuity or MRI findings; it was just a physician preference. Since the therapy selection was not randomized and blind, the result of this part should be interpreted cautiously. The explanation of different eventual outcome of 3 g and 5 g corticosteroid therapies may remain in the fact of overwhelming immunity suppression with high dose therapy. However, this will need to be elucidated by prospective double blind clinical trials.
The strength of the present study is the use of the survival method of analysis since standard methods of analysis such as logistic regression and mean time to reach the end point can give misleading results due to censored data. In addition, this study benefited from using the McDonald criteria to diagnose MS at a single center. In contrast, the limitations of this research are the inherent retrospective nature of the study, limited long-term follow up of the original cohort of 219 patients (109 patients).
In conclusion, 45% of Iranian patients referring to our center with first acute attack of ON developed CDMS after five years. The MRI lesions were the strongest independent risk factor of developing CDMS. Bilateral ON, female gender, and CSF abnormalities were also important factors in predicting CDMS development. In addition, younger age in males was more likely to lead to development of CDMS. The inadvertent effect of high dose corticosteroid therapy needs to be investigated with double controlled randomized clinical trials.
